Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5
Authors
Keywords
-
Journal
ANTIVIRAL RESEARCH
Volume 219, Issue -, Pages 105737
Publisher
Elsevier BV
Online
2023-10-24
DOI
10.1016/j.antiviral.2023.105737
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation
- (2023) Chiara Acchioni et al. VIROLOGY
- AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model
- (2022) Kai Lin et al. PLoS Neglected Tropical Diseases
- A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response
- (2022) Zhao Gao et al. PLoS Pathogens
- An overview on small molecules acting as broad spectrum-agents for yellow fever infection
- (2022) Jenny Desantis et al. Expert Opinion on Drug Discovery
- Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo
- (2022) Xijing Qian et al. Emerging Microbes & Infections
- High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses
- (2022) Cuiling Ding et al. Viruses-Basel
- Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo
- (2021) Haoran Peng et al. Science China-Life Sciences
- Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
- (2020) Fatemeh Heidary et al. JOURNAL OF ANTIBIOTICS
- Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
- (2020) Chaima Mouffouk et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Risk of yellow fever virus transmission in the Asia-Pacific region
- (2020) Lucy de Guilhem de Lataillade et al. Nature Communications
- Molecular Basis for Arbovirus Transmission by Aedes aegypti Mosquitoes
- (2019) Luis A. Alonso-Palomares et al. INTERVIROLOGY
- Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure
- (2019) Érica Araújo Mendes et al. Annals of Hepatology
- Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses
- (2019) Anna Dubankova et al. ANTIVIRAL RESEARCH
- Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016–2019
- (2019) Marta Giovanetti et al. JOURNAL OF VIROLOGY
- Flavivirus RNA-Dependent RNA Polymerase Interacts with Genome UTRs and Viral Proteins to Facilitate Flavivirus RNA Replication
- (2019) YanPing Duan et al. Viruses-Basel
- Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study)
- (2019) Claudia Figueiredo-Mello et al. BMJ Open
- Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe
- (2018) Florian Douam et al. TRENDS IN MICROBIOLOGY
- Challenges and opportunities in controlling mosquito-borne infections
- (2018) Neil M. Ferguson NATURE
- The reemergence of yellow fever
- (2018) Alan D. T. Barrett SCIENCE
- Triiodothyroacetic acid in health and disease
- (2017) Stefan Groeneweg et al. JOURNAL OF ENDOCRINOLOGY
- Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study
- (2017) Moritz U G Kraemer et al. LANCET INFECTIOUS DISEASES
- Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
- (2017) Freya M Shearer et al. LANCET INFECTIOUS DISEASES
- Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
- (2017) Joanne M. Donkers et al. Scientific Reports
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein
- (2016) Fang Guo et al. JOURNAL OF VIROLOGY
- BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model
- (2014) Justin G. Julander et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data
- (2014) Tini Garske et al. PLOS MEDICINE
- Genomic and Phylogenetic Characterization of Brazilian Yellow Fever Virus Strains
- (2012) M. R. T. Nunes et al. JOURNAL OF VIROLOGY
- Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster model
- (2010) Justin G. Julander et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started